长期口服抗凝药物治疗的患者经皮冠状动脉支架置入术后的抗栓治疗
被引量:5
摘要
目前阿司匹林和氯吡格雷的双联抗血小板治疗已经成为冠状动脉支架置入术后的标准抗栓方案,但约有5%接受冠状动脉支架置入术的患者需要长期口服维生素K拮抗剂治疗,对这些患者的抗栓治疗方案尚未统一,也是困扰心内科医师的难题之一。本文总结了接受长期口服抗凝药物治疗的患者行冠状动脉支架置入术后多种抗栓治疗方法,以寻求对此类患者的最佳治疗方案。
出处
《中国循环杂志》
CSCD
北大核心
2010年第1期71-73,共3页
Chinese Circulation Journal
参考文献19
-
1Silber S, Albertsson P, Francisco F, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J, 2005, 26 : 804-847. 被引量:1
-
2Gerard H, Martine G, Claude LF, et al. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med, 2006,3 (12) :673-680. 被引量:1
-
3Vaziri S, Bikkina M, Levy D, et al. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ⅰ. Clinical features of patients at risk. Ann Intern Med, 1992, 116:1-5. 被引量:1
-
4Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke : results from the national registry of atrial fibrillation. JAMA ,2001,255 : 2864-2870. 被引量:1
-
5Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral antieoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events ( ACTIVE W ) : a randomised eontrolled trial. Lancet, 2006,367 : 1903- 1912. 被引量:1
-
6Aguilar M, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient isehemic attacks. The Cochrane Database of Systematic Reviews,2005,4 : 1925. 被引量:1
-
7Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Eng J Med, 1999,340 : 901-907. 被引量:1
-
8Schlitt A, Bardeleben RS, Ehrlich A, et al. Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement ( CAPTA). Thromb Res ,2003,109 : 131-135. 被引量:1
-
9Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med, 1997,336: 1506-1511. 被引量:1
-
10Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation ,2004,100 : 1658-1663. 被引量:1
二级参考文献10
-
1韩雅玲.冠心病抗血小板治疗:热点与展望[J].中华医学杂志,2005,85(31):2171-2172. 被引量:8
-
2Popma JJ, Berger P, Ohman EM, et al. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126 (3 Suppl): 576S. 被引量:1
-
3Gunnar R.M, Bourdillon PD, Dixon DW, ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation, 1990, 82(2): 664. 被引量:1
-
4Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.J Am Coll Cardiol, 1988, 11(1) : 1. 被引量:1
-
5Orford JL, Fasseas P, Melbv S, et al. Safety and efficacy of aspirin, elopidogrel, and warfarin after coronary stent placement in patients with an indication for anticaagulation Am Heart J, 2004, 147(3) : 463. 被引量:1
-
6Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol, 2006, 18 (4) : 162. 被引量:1
-
7Fuster V, Ryden LE, Carmom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J, 2006, 27 (16) : 1979. 被引量:1
-
8Anderson JL, Adams CD, Antrnan EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2007, 50(7):e1. 被引量:1
-
9Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy., an ACTIVE W Substudy. J Am CoU Cardiol, 2007, 50(22) : 2156. 被引量:1
-
10韩雅玲.个体化治疗——冠心病抗栓治疗的方向[J].解放军医学杂志,2008,33(8):921-922. 被引量:11
共引文献4
-
1姚均迪,朱永武,赵峰,沈彬,赵宏坤,蒋逸风,林晓耘.华法林抗凝治疗致出血23例原因分析[J].人民军医,2009,52(12):836-836. 被引量:2
-
2万兴才,黄丙森,赵利华.人工心脏瓣膜置换术后前降支慢性闭塞性病变开通致冠脉穿孔1例[J].中国老年学杂志,2013,33(2):411-413. 被引量:2
-
3穆彬,郭磊.不同抗凝强度华法林对老年NVAF患者肾功能影响的观察[J].人民军医,2017,60(3):263-264.
-
4李占鲁,王敏,赵炎波,黄翯.服用新型口服抗凝药合并冠状动脉粥样硬化性心脏病患者冠状动脉介入治疗围术期抗栓策略的探讨[J].中国现代医生,2020,58(30):46-49. 被引量:4
同被引文献37
-
1金平.急诊PTCA及支架植入术治疗急性心肌梗死的护理体会[J].中国医药指南,2008,6(24):48-49. 被引量:3
-
2赵莉.经皮腔内冠状动脉成形术及支架植入术抗凝治疗的观察与护理[J].职业卫生与病伤,2004,19(3):214-214. 被引量:1
-
3张华,倪琴,吴歆华.改良低分子肝素注射手法减少皮下淤血的护理观察[J].解放军护理杂志,2005,22(6):96-97. 被引量:19
-
4吴学勤,郭晓岚,汤雁玲,问芳芳.直接PCI治疗急性心肌梗死伴房室传导阻滞患者的护理[J].中国实用护理杂志,2006,22(10):16-17. 被引量:39
-
5Babapulle MN,Joseph L,Belisle P,et al.A hierarchical bayesian meta-analysis of randomised clinical trials of drug-eluting stents.Lancet,2004,364:583-591. 被引量:1
-
6Finn AV,Joner M,Nakazawa G,et al.Pathological correlates of late drug-eluting stent thrombosis:strut coverage as a marker of endothelialization.Circulation,2007,115:2435-2441. 被引量:1
-
7Guagliumi G,Sirbu V.Optical coherence tomography:high resolution intravascular imaging to evaluate vascular healing after coronary stenting.Catheteri Cardiovasc Interv,2008,72:237-247. 被引量:1
-
8Tanigawa J,Barlis P,Di Mario C.Intravascular optical coherence tomography:optimisation of image acquisition and quantitative assessment of stent strut apposition.EuroInterv,2007,3:128-136. 被引量:1
-
9Tanigawa J,Barlis P,Dimopoulos K,et al.The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography.Int J Cardiol,2009,134:180-188. 被引量:1
-
10Kume T,Akasaka T,Kawamoto T,et al.Assessment of coronary arterial thrombus by optical coherence tomography.Am J Cardiol,2006,97:1713-1717. 被引量:1
引证文献5
-
1范春雨,Kim Jung-Sun,Kim Tae-Hoon,吕吉元.光学相干断层成像评价佐它莫司药物洗脱支架置入后的血管愈合情况[J].中国循环杂志,2011,26(5):343-346.
-
2王艳蕊,何爱玉.冠脉介入围术期强化抗栓治疗出血并发症的观察与护理[J].中国医刊,2013,48(8):95-96. 被引量:10
-
3殷红祥.探讨对房颤患者抗栓治疗的效果[J].中国实用医药,2014,9(29):141-142. 被引量:1
-
4褚瑜光,李军,宋庆桥,魏艺,张菀桐,闫芳,胡元会.冠心病患者血栓弹力图与中医血瘀证的相关性研究[J].北京中医药,2015,34(9):683-685. 被引量:4
-
5冯丽芳.冠状动脉支架术后患者应用抗凝药物治疗的观察与护理探讨[J].中国医药指南,2018,16(5):256-257. 被引量:3
二级引证文献18
-
1雷力成,刘岩,杨水祥.冠心病介入治疗患者的个性特征及情绪状态分析[J].中国医刊,2014,49(5):56-58. 被引量:6
-
2徐海燕,陈雨,蒙涛,马树人,谢雄伟.平均血小板体积联合SYNTAX积分评估介入治疗非ST段抬高心肌梗死患者远期预后的价值[J].中国心血管病研究,2015,13(9):831-835. 被引量:5
-
3马士容.PCI围术期舒适护理对冠心病患者心理状态及预后的影响[J].中华全科医学,2015,13(11):1866-1868. 被引量:45
-
4董辉.经皮冠状动脉介入围术期并发出血情况分析及临床护理[J].齐鲁护理杂志,2016,22(22):85-86. 被引量:1
-
5戴美凤,陆传新,赵宏坤,朱永武,蒋逸风,沈彬.替罗非班在大量血栓负荷的急性STEMI患者急诊介入治疗中的应用[J].心血管康复医学杂志,2016,25(5):516-519. 被引量:4
-
6满广珍,郑春风.出血风险评估在房颤患者行左心耳封堵术护理中的应用[J].中国卫生标准管理,2016,7(24):256-258.
-
7唐克强,王芳,李腾龙.冠状动脉粥样硬化性心脏病患者经皮冠状动脉介入治疗围手术期出血的相关影响因素及生存状况研究[J].中国现代医学杂志,2017,27(4):98-102. 被引量:12
-
8李健,王小渠.老年心房纤颤患者不同抗栓治疗方案的临床效果观察[J].医药前沿,2017,7(11):49-50. 被引量:1
-
9葛庆青,陈鸿尔,孙兰飞.经皮冠状动脉介入术后消化道出血55例的护理[J].护理与康复,2017,16(5):444-445.
-
10夏雯.优质护理对冠心病经皮冠脉介入术后并发上消化道出血患者止血时间、不良情绪的影响[J].现代消化及介入诊疗,2017,22(4):566-568. 被引量:21
-
1刘艳红,贾金广,于洪涛.IL-6,C-反应蛋白及D-二聚体在慢性阻塞性肺疾病急性加重期的变化及意义[J].医药论坛杂志,2011,32(4):31-33. 被引量:7
-
2蔡燕.单纯抗凝治疗肺栓塞的疗效观察[J].航空航天医学杂志,2016,27(2):204-206. 被引量:1
-
3陈小微,吴建胜,吴小丽.以消化道为首发症状的白塞病临床诊治分析[J].实用医学杂志,2005,21(11):1173-1174. 被引量:3
-
4何丹.川崎病65例随访分析[J].中原医刊,2006,33(5):42-43.
-
5周海玲.抗凝药物治疗慢性阻塞性肺疾病合并不成比例的肺动脉高压的临床观察[J].中华肺部疾病杂志(电子版),2011,4(3):56-58. 被引量:4
-
6杨新春.临床实践中PCI患者的抗血小板治疗[J].中华医学信息导报,2012,27(24):13-13. 被引量:1
-
7陆慰萱.抗凝药物与肺血栓栓塞症的临床应用评价[J].中国医院用药评价与分析,2003,3(2):71-74. 被引量:3
-
8朱敏玲.抗凝药物治疗不稳定型心绞痛32例临床观察[J].哈尔滨医药,2002,22(4):70-70.
-
9盖庆玲,王立华,孙吉昌.肺结核并发肺栓塞的诊断与治疗[J].中国防痨杂志,2007,29(6):529-531. 被引量:4
-
10吴延庆,程晓曙,吴清华,李菊香,程开诚,程应樟,李萍,苏海,罗伟.华法令对非瓣膜性心房颤动发生血栓栓塞的影响[J].临床心血管病杂志,2003,19(9):551-551. 被引量:13